LinkedIn Announcement:
December 2, 2024
Pharmidex is excited to share that our Head of Oncology,
Dr. Christopher Ireson, will be attending the
DRUG DISCOVERY Paris: SINGLE CELL GENOMICS forum on 3 December 2024! 🎉
This event, organized by ELRIG UK (https://lnkd.in/enEA8GuS), brings together thought leaders in drug discovery and genomics, focusing on the latest advancements in single-cell technologies.
Dr. Ireson is eager to connect with fellow attendees to discuss cutting-edge research and explore potential collaborations. If you’re attending, he’d be delighted to meet with you, don’t hesitate to reach out or catch him at the event!
#Pharmidex #DrugDiscovery #SingleCellGenomics #OncologyResearch
At Pharmidex , we deliver high-quality LC-MS bioanalysis to support drug development across a wide range of analysis. Our experienced team supports preclinical, translational and clinical studies, providing accurate, reliable data under GLP and GCP to help drive confident decision-making. Learn more about our LC-MS capabilities: https://www.pharmidex.com/Discovery-Bioanalysis
Pharmidex offers high-quality Clinical Chemistry services delivering accurate, reliable data to support drug development. Our expert team and robust, quality-driven workflows enable trusted results that help accelerate decision-making and strengthen collaboration with pharma companies, CROs and academic partners. By working together, we support better science and more efficient drug development. 👉 Learn more: https://www.pharmidex.com/Clinical-chemistry
Pharmidex is delighted to share that Ash Alavijeh , Head of Operations, will be attending the UK BioIndustry Association (BIA) Annual Gala Dinner at the Roundhouse, London. Ash is looking forward to connecting with pharma and biotech colleagues to explore new collaborations, partnerships, and opportunities, all with the shared goal of advancing drug discovery and development. If you’re attending, feel free to connect with Ash this evening.
